|
Press Releases |
|
|
|
Tuesday, September 6, 2022 |
|
Avance Clinical Announces North American CRO Acquisition to Expand Later Phase Services for Biotechs |
Avance Clinical, the Australian CRO for biotechs, has expanded into North America with the acquisition of CRO partner company C3 Research Associates to enable biotech clients a seamless journey from early phase to later phase studies. Avance Clinical has backing from private equity group Riverside Company for their global expansion program. more info >> |
|
Monday, August 29, 2022 |
|
Avance Clinical Sponsors Biotech Company of the Year Awards at Informa Pharma Intelligence Awards 2022 |
Avance Clinical, the leading Australian CRO for international biotechs, is sponsoring two awards - Biotech Company of the Year Private and Public - at the Informa Pharma Intelligence Awards 2022 and is also a finalist for the Best Contract Research Organization in APAC. more info >> |
|
Tuesday, April 19, 2022 |
|
Avance Clinical Finalist for Informa Pharma Intelligence Awards 2022 - Best Contract Research Organization in APAC |
Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has been selected as a finalist for the Best Contract Research Organization in APAC by Informa Pharma Intelligence. more info >> |
|
Thursday, March 31, 2022 |
|
Avance Clinical Announces New Office Opening in Melbourne |
Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has opened new offices in Melbourne to support its growing clinical team in the greater Melbourne region. more info >> |
|
Wednesday, March 2, 2022 |
|
Avance Clinical Announces New Office Opening in Sydney |
Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has opened new offices in Sydney to support its growing clinical team in the greater Sydney region. more info >> |
|
Tuesday, January 18, 2022 |
|
Avance Clinical Announces Major PE Investment for US Expansion at Biotech Showcase 2022 |
Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has secured a significant investment from global private equity firm, The Riverside Company (Riverside), to support further regional and global expansion. The investment values the company in excess of $200m. more info >> |
|
Tuesday, October 19, 2021 |
|
Avance Clinical Client News: XWPharma Initiates First-in-Human Studies of XW10508, in Development for Fast-acting Relief of Treatment-Resistant Depression and Chronic Pain |
Avance Clinical, the largest premium Australian CRO for international biotechs, is pleased to share the news that its client XWPharma Ltd. has announced dosing of subjects in its first-in-human study evaluating XW10508, the Company's novel, patented, glutamatergic NMDA antagonist and AMPA activator in development as an oral, once-daily therapy for the treatment of treatment-resistant depression and chronic pain. more info >> |
|
Tuesday, August 10, 2021 |
|
Avance Clinical Awarded Frost & Sullivan 2021 Asia-Pacific CRO Best Practices Award for Customer Value Leadership |
Avance Clinical, the largest premium Australian CRO for international biotechs, has been awarded the prestigious Frost & Sullivan 2021 Asia-Pacific CRO Customer Value Leadership Award, the second consecutive Asia-Pacific (APAC) CRO Best Practices Award for the company from Frost & Sullivan. more info >> |
|
Friday, July 9, 2021 |
|
Avance Clinical Congratulates Client Tetherex Pharmaceuticals on Initiation of Dosing in a Phase 1 Clinical Study Using a Novel Single-Cycle Adenovirus Vaccine Strategy in Australia |
The largest Australian full-service CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical today congratulated client Tetherex Pharmaceuticals on first patient dosing for its Phase 1 vaccine clinical trial. more info >> |
|
Monday, June 28, 2021 |
|
Avance Clinical Appoints Asia Biotech Specialist to Support APAC Growth |
The leading Australian CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical today announced the appointment of APAC expert Andy Hu as Business Development Manager APAC to support increasing biotech clinical trial demand from the region. more info >> |
|
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Mitsubishi Motors Posts Record Sales in the Philippines in FY2023
Apr 24, 2024 13:56 JST
|
|
|
NEC Develops High-speed Generative AI Large Language Models (LLM) with World-class Performance
Apr 24, 2024 13:25 JST
|
|
|
Dogs Thrive on Vegan Diets, Demonstrates the Most Comprehensive Study So Far
Apr 24, 2024 07:00 HKT/SGT
|
|
|
Graid Technology Announces Software Update, Delivers Enhanced Levels of Data Integrity and Business Continuity
Apr 23, 2024 23:00 HKT/SGT
|
|
|
China Medical System: New Drug Application of Desidustat Tablets Accepted in China
Apr 23, 2024 22:00 HKT/SGT
|
|
|
GA-ASI Mojave Lights Up the Yuma Desert in Live-Fire Demonstration
Apr 23, 2024 20:00 HKT/SGT
|
|
|
2024 U.S. Open Polo Championship(R) Closes Out Historic High-Goal Season at the Sport's Premier Destination in Palm Beach County, Florida
Apr 23, 2024 20:00 HKT/SGT
|
|
|
HKTDC Home InStyle, Fashion InStyle forge global business opportunities
Apr 23, 2024 19:00 HKT/SGT
|
|
|
Masverse Unveils Groundbreaking Blockchain Platform
Apr 23, 2024 18:00 HKT/SGT
|
|
|
Dubai Sets the Stage for Digital Innovation: Unveiling the Inaugural Digital Transformation Summit
Apr 23, 2024 17:56 HKT/SGT
|
|
|
New Contaminants, Food Testing & More: analytica Convention 2024 Focuses on Vietnam's Laboratory Needs
Apr 23, 2024 16:00 HKT/SGT
|
|
|
Singapore Unveils Its First Live Painting Event Featuring ADHD Artists, Inspired by 'Collide' by Tay Guan Hin"
Apr 23, 2024 14:28 HKT/SGT
|
|
|
EM2AI Revolutionising the Dental Industry: New AI Products Promise Transparent Treatment Plans for Patients
Apr 23, 2024 14:00 HKT/SGT
|
|
|
Vietnam: Nutifood opts for innovative SIG DomeMini on-the-go carton bottle
Apr 23, 2024 14:00 HKT/SGT
|
|
|
Citi, UBS, GS view positive on Fosun's core business-focused strategy
Apr 23, 2024 12:28 HKT/SGT
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|